Genomic tools, research products, molecular diagnostics, NGS
Total Trials
25
As Lead Sponsor
12
As Collaborator
13
Total Enrollment
154,106
NCT00959504
Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA
Phase: N/A
Role: Lead Sponsor
Start: Aug 31, 2009
Completion: Sep 30, 2009
NCT02121873
The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage
Role: Collaborator
Start: Jul 31, 2011
Completion: Aug 31, 2012
NCT01426308
Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test
Start: Aug 31, 2011
Completion: Nov 30, 2011
NCT01463410
Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler
Start: Oct 31, 2011
Completion: Mar 31, 2013
NCT01899079
A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay
Start: Jun 30, 2013
Completion: Jul 31, 2014
NCT02268786
Single Embryo TrAnsfeR of Euploid Embryo
Start: Sep 30, 2014
Completion: Dec 31, 2016
NCT02808494
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
Start: Mar 31, 2016
Completion: Nov 20, 2017
NCT03590678
Collection of Whole Blood Specimens in Pregnant Women
Start: Feb 13, 2017
Completion: Dec 31, 2019
NCT03290469
NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants
Start: Sep 14, 2017
Completion: Jan 13, 2020
NCT03620110
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
Start: May 21, 2018
Completion: Dec 30, 2019
NCT03655223
Early Check: Expanded Screening in Newborns
Start: Oct 15, 2018
Completion: Dec 31, 2025
NCT04170985
NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology
Start: Nov 18, 2019
Completion: Jan 31, 2024
NCT04561089
Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel
Start: Feb 13, 2020
Completion: Feb 28, 2021
NCT04561102
Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population
Start: Sep 11, 2020
NCT04935138
Cell-free DNA Analysis of Chromosome Anomalies in Early Pregnancy Loss
Start: Jun 1, 2021
Completion: Dec 31, 2022
NCT05058937
A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre
Completion: May 31, 2026
NCT05049967
iKnow: A Prospective Study to Evaluate the Use of Multi-omics in Multi-System, Early Onset Disorders
Start: Nov 9, 2021
Completion: Dec 31, 2024
NCT05046444
Solving Riddles Through Sequencing
Start: Jan 19, 2022
Completion: Oct 1, 2026
NCT05372445
Microbiome and Health Indicators in People With Obesity, Prediabetes and Type 2 Diabetes Undergoing a Lifestyle Intervention
Start: May 30, 2022
NCT05990179
Genomic Uniformed-Screening Against Rare Disease In All Newborns
Start: Sep 6, 2022
Completion: Sep 30, 2029
NCT07201038
Ultrafast Whole Genome Sequencing for Childhood Cancer
Start: Oct 19, 2022
Completion: Oct 17, 2028
NCT05656183
CardioSeq: Impact of WGS in Individuals With CVD
Start: Jan 6, 2023
Completion: Jun 30, 2025
NCT05072275
Prospective Electronic Polygenic Risk Study
Start: Mar 31, 2023
Completion: Nov 30, 2023
NCT05858268
NeuralNET Cerebral Palsy Pilot Study
Start: Apr 14, 2023
Completion: Jan 31, 2026
NCT05175651
Prospective Electronic Polygenic Risk Study - Second Phase
Start: Jun 30, 2023
Completion: Jan 15, 2027
Loading map...